Phanes Therapeutics announces first patient with colorectal cancer (CRC) dosed in clinical study of spevatamig
SAN DIEGO, Oct. 14, 2026 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), announced that the first patient has been dosed in the […]
